Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05934370 · ClinicalTrials.gov registry record · NA
The Duke-Reinvestment Partners Community Collaborative (DRC)- Healthy Homes
A NA study of Asthma in Children, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05934370: Completed NA study of Asthma in Children, sponsored by Duke University.
NCT05934370 is a NA study of Asthma in Children that has completed, run by Duke University. The registered enrollment target is 36 participants, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05934370, a NA study of Asthma in Children, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this open-label, single arm home intervention feasibility study is to improve quality of life for children ages 4-16 years with asthma. The main questions it aims to answer are: * How can Home-Based Environmental Interventions (HEI) improve home air-quality problems in the home? * How can HEI improve asthma outcomes in children? Participants will be receiving HEI and completing asthma surveys.
Primary Outcome
A measure of satisfaction by distributing a satisfaction survey to each patient and caregiver
Conditions Studied
Interventions
- OTHER Home-Based Environmental Interventions (HEI)
Study Locations (1)
North Carolina
- Duke University Health System - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-07-20 |
| Est. Completion | 2024-11-19 |
| Phase | NA |
What the finished NCT05934370 record still lists
NCT05934370 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which Home-Based Environmental Interventions (HEI) is the first listed.
NCT05934370 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05934370 about?
NCT05934370 is a clinical study titled "The Duke-Reinvestment Partners Community Collaborative (DRC)- Healthy Homes". The goal of this open-label, single arm home intervention feasibility study is to improve quality of life for children ages 4-16 years with asthma. The main questions it aims to answer are: * How can Home-Based Environmental Interventions (HEI) improve home air-quality problems in the home? * How ...
What is the current status of trial NCT05934370?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-07-20. Estimated completion is 2024-11-19.
What conditions does trial NCT05934370 study?
This clinical trial studies the following conditions: Asthma in Children.
What interventions are being tested in trial NCT05934370?
The interventions under investigation include: Home-Based Environmental Interventions (HEI) (OTHER).
Who is sponsoring clinical trial NCT05934370?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05934370 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05934370's enrollment target sits among peer trials
36 34th of 44 higher than 10 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
-
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI